These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1045 related articles for article (PubMed ID: 8104124)

  • 1. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
    Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
    Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. II. Flavin-containing monooxygenase-mediated N-oxidation.
    Mani C; Hodgson E; Kupfer D
    Drug Metab Dispos; 1993; 21(4):657-61. PubMed ID: 8104125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of the proestrogenic pesticide methoxychlor by hepatic P450 monooxygenases in rats and humans. Dual pathways involving novel ortho ring-hydroxylation by CYP2B.
    Dehal SS; Kupfer D
    Drug Metab Dispos; 1994; 22(6):937-46. PubMed ID: 7895613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P-450-mediated activation and irreversible binding of the antiestrogen tamoxifen to proteins in rat and human liver: possible involvement of flavin-containing monooxygenases in tamoxifen activation.
    Mani C; Kupfer D
    Cancer Res; 1991 Nov; 51(22):6052-8. PubMed ID: 1933868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of cytochrome P4503A in catalysis of tamoxifen activation and covalent binding to rat and human liver microsomes.
    Mani C; Pearce R; Parkinson A; Kupfer D
    Carcinogenesis; 1994 Dec; 15(12):2715-20. PubMed ID: 8001226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of isozymes of cytochrome P-450 in the metabolism of N,N-dimethyl-4-aminoazobenzene in the rat.
    Levine WG; Lu AY
    Drug Metab Dispos; 1982; 10(2):102-9. PubMed ID: 6124393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The aromatase inactivator 4-hydroxyandrostenedione (4-OH-A) inhibits tamoxifen metabolism by rat hepatic cytochrome P-450 3A: potential for drug-drug interaction of tamoxifen and 4-OH-A in combined anti-breast cancer therapy.
    Dehal SS; Brodie AM; Kupfer D
    Drug Metab Dispos; 1999 Mar; 27(3):389-94. PubMed ID: 10064571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2D6 catalyzes tamoxifen 4-hydroxylation in human liver.
    Dehal SS; Kupfer D
    Cancer Res; 1997 Aug; 57(16):3402-6. PubMed ID: 9270005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
    Miyazawa M; Shindo M; Shimada T
    Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positional specificity for methyl-n-amylnitrosamine hydroxylation by cytochrome P-450 isozymes determined with monoclonal antibodies.
    Mirvish SS; Huang Q; Ji C; Wang S; Park SS; Gelboin HV
    Cancer Res; 1991 Feb; 51(4):1059-64. PubMed ID: 1997155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of CYP3A1, 2B1, and 2E1 in C-8 hydroxylation and CYP 1A2 and flavin-containing monooxygenase in N-demethylation of caffeine; identified by using inducer treated rat liver microsomes that are characterized with testosterone metabolic patterns.
    Chung WG; Roh HK; Kim HM; Cha YN
    Chem Biol Interact; 1998 May; 113(1):1-14. PubMed ID: 9630843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cytochrome P450 in oxazaphosphorine metabolism. Deactivation via N-dechloroethylation and activation via 4-hydroxylation catalyzed by distinct subsets of rat liver cytochromes P450.
    Yu L; Waxman DJ
    Drug Metab Dispos; 1996 Nov; 24(11):1254-62. PubMed ID: 8937861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo modulation of alternative pathways of P-450-catalyzed cyclophosphamide metabolism: impact on pharmacokinetics and antitumor activity.
    Yu LJ; Drewes P; Gustafsson K; Brain EG; Hecht JE; Waxman DJ
    J Pharmacol Exp Ther; 1999 Mar; 288(3):928-37. PubMed ID: 10027828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450IIIA enzymes in rat liver microsomes: involvement in C3-hydroxylation of diazepam and nordazepam but not N-dealkylation of diazepam and temazepam.
    Reilly PE; Thompson DA; Mason SR; Hooper WD
    Mol Pharmacol; 1990 May; 37(5):767-74. PubMed ID: 1971091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminopyrine metabolism by multiple forms of cytochrome P-450 from rat liver microsomes: simultaneous quantitation of four aminopyrine metabolites by high-performance liquid chromatography.
    Imaoka S; Inoue K; Funae Y
    Arch Biochem Biophys; 1988 Aug; 265(1):159-70. PubMed ID: 3415241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of tamoxifen-4-hydroxylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), beta-naphthoflavone (beta NF), and phenobarbital (PB) in avian liver: identification of P450 TCDDAA as catalyst of 4-hydroxylation induced by TCDD and beta NF.
    Kupfer D; Mani C; Lee CA; Rifkind AB
    Cancer Res; 1994 Jun; 54(12):3140-4. PubMed ID: 8205532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of 2-acetylaminofluorene by two 3-methylcholanthrene-inducible forms of rat liver cytochrome P-450.
    Goldstein JA; Weaver R; Sundheimer DW
    Cancer Res; 1984 Sep; 44(9):3768-71. PubMed ID: 6744296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotransformation of N,N',N''-triethylenethiophosphoramide: oxidative desulfuration to yield N,N',N''-triethylenephosphoramide associated with suicide inactivation of a phenobarbital-inducible hepatic P-450 monooxygenase.
    Ng SF; Waxman DJ
    Cancer Res; 1990 Feb; 50(3):464-71. PubMed ID: 2105156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ring hydroxylation of [o-3H]methoxychlor as a probe for liver microsomal CYP2B activity: potential for in vivo CYP2B assay.
    Stresser DM; Dehal SS; Kupfer D
    Anal Biochem; 1996 Jan; 233(1):100-7. PubMed ID: 8789153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo effects of the arylamine human immunodeficiency virus protease inhibitor 4R-(4alpha,5alpha,6beta, 7beta)-1-[(3-(1-imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)m ethyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1, 3-diazepin-2-one (SD894) on rat hepatic cytochrome P450 2B and 3A.
    Grubb MF; Diamond S; Christ DD
    Drug Metab Dispos; 1997 Dec; 25(12):1424-8. PubMed ID: 9394033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.